Silvia Ajossa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Silvia Ajossa has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Stefano Guerriero
Department of Obstetrics and Gynecology University of Cagliari, Policlinico Universitario Duilio Casula Cagliari Italy
9 shared publications - Valerio Mais
Department of Surgical Sciences, University of Cagliari Medical School, 09042 Cagliari, Italy
5 shared publications - Juan Luis Alcázar
Department of Obstetrics and Gynecology Hospital Quironsalud Málaga Spain
4 shared publications - Anna Maria Paoletti
Department of Obstetrics and Gynecology, University of Cagliari, Cagliari, Italy
3 shared publications - Bruno Piras
Struttura Semplice Dipartimentale di Emergenze in Ostetricia e Ginecologia Azienda Ospedaliero Universitaria Cagliari–Policlinico Duilio Casula Monserrato Italy
3 shared publications - Monica Pilloni
B Department of Obstetrics and Gynecology, University Hospital of Cagliari , Cagliari , Italy
3 shared publications
Latest Publications
- Open Access
- 9 July 2026
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 313 (1)
Attachment, emotion regulation and quality of life in women with a diagnosis of endometriosis: a cross-sectional study
Purpose: Endometriosis, a prevalent gynecological condition, significantly impacts physical, psychological, and social well-being. This study explores the relationship between attachment styles, emotion regulation difficulties, and quality of life in women with endometriosis. Drawing on attachment theory, the study hypothesized that secure attachment would correlate with fewer emotion regulation difficulties and higher quality of life, while insecure attachment styles would correlate with greater difficulties and lower quality of life. Methods: The study included 354 Italian women diagnosed with endometriosis. Participants completed the Relationship Questionnaire to assess attachment styles, the Difficulties in Emotion Regulation Scale—Short Form to evaluate emotion regulation, and the WHOQOL–BREF to measure quality of life. Data analysis employed structural equation modeling to examine the direct and indirect effects of attachment styles on quality of life, mediated by emotion regulation difficulties. Results: Results confirmed the hypotheses: secure attachment was associated with better emotion regulation and higher quality of life, whereas preoccupied and fearful attachment styles were linked to greater emotion regulation difficulties and lower quality of life. The dismissing attachment style did not show significant associations. Conclusions: The findings underscore the importance of addressing emotion regulation in therapeutic interventions for women with endometriosis.
- 9 July 2026
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 313 (1)
Open AccessAttachment, emotion regulation and quality of life in women with a diagnosis of endometriosis: a cross-sectional study
Purpose: Endometriosis, a prevalent gynecological condition, significantly impacts physical, psychological, and social well-being. This study explores the relationship between attachment styles, emotion regulation difficulties, and quality of life in women with endometriosis. Drawing on attachment theory, the study hypothesized that secure attachment would correlate with fewer emotion regulation difficulties and higher quality of life, while insecure attachment styles would correlate with greater difficulties and lower quality of life. Methods: The study included 354 Italian women diagnosed with endometriosis. Participants completed the Relationship Questionnaire to assess attachment styles, the Difficulties in Emotion Regulation Scale—Short Form to evaluate emotion regulation, and the WHOQOL–BREF to measure quality of life. Data analysis employed structural equation modeling to examine the direct and indirect effects of attachment styles on quality of life, mediated by emotion regulation difficulties. Results: Results confirmed the hypotheses: secure attachment was associated with better emotion regulation and higher quality of life, whereas preoccupied and fearful attachment styles were linked to greater emotion regulation difficulties and lower quality of life. The dismissing attachment style did not show significant associations. Conclusions: The findings underscore the importance of addressing emotion regulation in therapeutic interventions for women with endometriosis.
- Open Access
- 23 August 2025
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 67 (1) , 7-14
Transvaginal ultrasound for detecting parametrial involvement in suspected deep pelvic endometriosis: updated meta‐analysis
Objective: To perform an updated meta‐analysis evaluating the diagnostic performance of transvaginal ultrasound (TVS) for detecting lateral parametrial involvement in women with suspected deep pelvic endometriosis. Methods: A literature search was performed in the Web of Science, PubMed and Scopus databases from January 2021 to May 2024 for studies evaluating TVS for detecting parametrial involvement in women with suspected deep pelvic endometriosis, using laparoscopy with or without histology as the reference standard. The information gathered was combined with data from our previous meta‐analysis on this topic. Pooled sensitivity and specificity were calculated overall and for subgroup analyses considering parametrial laterality. The Quality Assessment of Diagnostic Accuracy Studies‐2 (QUADAS‐2) tool was used to evaluate study quality. Results: After exclusions, four new studies fulfilling the selection criteria were identified. Combined with the four studies included in our previous meta‐analysis, eight studies including a total of 6728 women (13 456 parametria) were included. The mean prevalence of parametrial involvement was 21.3%. The pooled sensitivity and specificity of TVS for detecting parametrial involvement were 63% (95% CI, 31–86%) and 98% (95% CI, 96–99%), respectively. When considering only the five studies that reported laterality, the corresponding values were 85% (95% CI, 64–95%) and 98% (95% CI, 92–99%) for the left parametrium and 84% (95% CI, 61–94%) and 97% (95% CI, 92–99%) for the right parametrium. Heterogeneity was high for the overall analysis and subgroup analyses. Conclusions: The diagnostic performance of TVS for detecting parametrial involvement in women with suspected deep pelvic endometriosis is better than that reported previously. This may be attributable to the use of a standardized TVS scanning technique and improved knowledge of pelvic ultrasound anatomy. Accurate parametrial assessment could improve surgical planning and patient outcome. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
- 23 August 2025
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 67 (1) , 7-14
Open AccessTransvaginal ultrasound for detecting parametrial involvement in suspected deep pelvic endometriosis: updated meta‐analysis
Objective: To perform an updated meta‐analysis evaluating the diagnostic performance of transvaginal ultrasound (TVS) for detecting lateral parametrial involvement in women with suspected deep pelvic endometriosis. Methods: A literature search was performed in the Web of Science, PubMed and Scopus databases from January 2021 to May 2024 for studies evaluating TVS for detecting parametrial involvement in women with suspected deep pelvic endometriosis, using laparoscopy with or without histology as the reference standard. The information gathered was combined with data from our previous meta‐analysis on this topic. Pooled sensitivity and specificity were calculated overall and for subgroup analyses considering parametrial laterality. The Quality Assessment of Diagnostic Accuracy Studies‐2 (QUADAS‐2) tool was used to evaluate study quality. Results: After exclusions, four new studies fulfilling the selection criteria were identified. Combined with the four studies included in our previous meta‐analysis, eight studies including a total of 6728 women (13 456 parametria) were included. The mean prevalence of parametrial involvement was 21.3%. The pooled sensitivity and specificity of TVS for detecting parametrial involvement were 63% (95% CI, 31–86%) and 98% (95% CI, 96–99%), respectively. When considering only the five studies that reported laterality, the corresponding values were 85% (95% CI, 64–95%) and 98% (95% CI, 92–99%) for the left parametrium and 84% (95% CI, 61–94%) and 97% (95% CI, 92–99%) for the right parametrium. Heterogeneity was high for the overall analysis and subgroup analyses. Conclusions: The diagnostic performance of TVS for detecting parametrial involvement in women with suspected deep pelvic endometriosis is better than that reported previously. This may be attributable to the use of a standardized TVS scanning technique and improved knowledge of pelvic ultrasound anatomy. Accurate parametrial assessment could improve surgical planning and patient outcome. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
- 4 March 2024
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 63 (4) , 575-576
Coronal plane on three‐dimensional ultrasound in diagnosis of ectopic pregnancy
- 4 March 2024
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 63 (4) , 575-576
Coronal plane on three‐dimensional ultrasound in diagnosis of ectopic pregnancy
- 22 May 2019
- Published by Taylor & Francis
- p. 82-95
Uterine Myoma
Uterine fibroids (also known as leiomyomas or myomas) are the most common type of benign uterine tumors that originate from the myometrium, and are made of extracellular matrix with collagen, fibronectin, and proteoglycans. 1
- 22 May 2019
- Published by Taylor & Francis
- p. 82-95
Uterine Myoma
Uterine fibroids (also known as leiomyomas or myomas) are the most common type of benign uterine tumors that originate from the myometrium, and are made of extracellular matrix with collagen, fibronectin, and proteoglycans. 1
- 22 May 2019
- Published by Taylor & Francis
- p. 20-33
Pelvic Endometriosis
Endometriosis is a chronic multifactorial disease. It is caused by the spread of endometrial glands and stroma outside the uterine cavity. Because of the subsequent growth of these ectopic implants, the woman affected presents with an inflammatory chronic process responsible for pelvic pain and severe dysfunction of the pelvic organs. 1
- 22 May 2019
- Published by Taylor & Francis
- p. 20-33
Pelvic Endometriosis
Endometriosis is a chronic multifactorial disease. It is caused by the spread of endometrial glands and stroma outside the uterine cavity. Because of the subsequent growth of these ectopic implants, the woman affected presents with an inflammatory chronic process responsible for pelvic pain and severe dysfunction of the pelvic organs. 1
- 1 March 2019
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 35 (9) , 756-761
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health
This observational study was conducted in premenopausal women who presented themselves at the Obstetrics and Gynecology Department of the University Hospital of Cagliari (Italy), for heavy menstrual bleeding (HMB) dependent on uterine myomas. After a screening visit, 19 women without contraindications to ulipristal acetate (UPA) treatment, were included in the study that envisaged 12 months of observation in which each subject was asked to assume UPA (tablet of 5 mg, ESMYA®, one tablet a day for 3 months: first cycle) two menstrual cycles of interruption and a second ESMYA® cycle, followed by 3 months of observation (third follow-up month, visit 4). The significant decrease of myoma volume, diagnosed after the first ESMYA® cycle, persisted until the visit 4. The HMB significantly decreased during the ESMYA® treatment and persisted until visit 4. The quality of life (QoL), evaluated with the questionnaire SF-36, significantly improved during the study. The values of estradiol (E2), biochemical parameters of bone metabolism, as well as those of lumbar and hip bone mineral density, did not change during the study in comparison with basal levels. The efficacy of two repeated ESMYA® cycles to treat uterine myomas and their related symptoms improves the QoL without interfering with bone health.
- 1 March 2019
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 35 (9) , 756-761
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health
This observational study was conducted in premenopausal women who presented themselves at the Obstetrics and Gynecology Department of the University Hospital of Cagliari (Italy), for heavy menstrual bleeding (HMB) dependent on uterine myomas. After a screening visit, 19 women without contraindications to ulipristal acetate (UPA) treatment, were included in the study that envisaged 12 months of observation in which each subject was asked to assume UPA (tablet of 5 mg, ESMYA®, one tablet a day for 3 months: first cycle) two menstrual cycles of interruption and a second ESMYA® cycle, followed by 3 months of observation (third follow-up month, visit 4). The significant decrease of myoma volume, diagnosed after the first ESMYA® cycle, persisted until the visit 4. The HMB significantly decreased during the ESMYA® treatment and persisted until visit 4. The quality of life (QoL), evaluated with the questionnaire SF-36, significantly improved during the study. The values of estradiol (E2), biochemical parameters of bone metabolism, as well as those of lumbar and hip bone mineral density, did not change during the study in comparison with basal levels. The efficacy of two repeated ESMYA® cycles to treat uterine myomas and their related symptoms improves the QoL without interfering with bone health.
- 26 April 2018
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 27 (5) , 497-505
Vilaprisan for treating uterine fibroids
Introduction: The medical strategy to antagonize myoma size and related-symptoms is to reduce estrogen and progesterone activity on myomas. This can be obtained with the GnRH agonist (GnRHa) or with compounds that antagonize progesterone stimulatory activity on myomas. Selective progesterone receptor modulators (SPRMs) bind progesterone receptor (PR), leading to both agonist and antagonist effects. The result of SPRMs’s action is tissue-specific and it depends on the particular affinity and strength of each SPRM. Area covered: Ulipristal acetate (UPA) is the first SPRM registered for myoma treatment. UPA reduces heavy uterine bleeding within 7 days from the onset of treatment, whereas a longer time is required with GnRHa treatment. Vilaprisan is a novel powerful SPRM. Phase I and II studies give encouraging results on the efficacy of vilaprisan at different doses. Like other SPRMs, vilaprisan induces benign changes of endometrium (PR modulator-associated endometrial changes, PAECs). These disappear as treatment is discontinued. Unlike GnRHa treatment, neither UPA nor vilaprisan induce hypoestrogenism and associated symptoms. Phase III studies are ongoing to confirm efficacy and safety of vilaprisan in long-term treatment of symptomatic fibroids. Expert opinion: It is fundamental to underline the rapidity of action (only 3 days) in the control of myoma-related bleeding.
- 26 April 2018
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 27 (5) , 497-505
Vilaprisan for treating uterine fibroids
Introduction: The medical strategy to antagonize myoma size and related-symptoms is to reduce estrogen and progesterone activity on myomas. This can be obtained with the GnRH agonist (GnRHa) or with compounds that antagonize progesterone stimulatory activity on myomas. Selective progesterone receptor modulators (SPRMs) bind progesterone receptor (PR), leading to both agonist and antagonist effects. The result of SPRMs’s action is tissue-specific and it depends on the particular affinity and strength of each SPRM. Area covered: Ulipristal acetate (UPA) is the first SPRM registered for myoma treatment. UPA reduces heavy uterine bleeding within 7 days from the onset of treatment, whereas a longer time is required with GnRHa treatment. Vilaprisan is a novel powerful SPRM. Phase I and II studies give encouraging results on the efficacy of vilaprisan at different doses. Like other SPRMs, vilaprisan induces benign changes of endometrium (PR modulator-associated endometrial changes, PAECs). These disappear as treatment is discontinued. Unlike GnRHa treatment, neither UPA nor vilaprisan induce hypoestrogenism and associated symptoms. Phase III studies are ongoing to confirm efficacy and safety of vilaprisan in long-term treatment of symptomatic fibroids. Expert opinion: It is fundamental to underline the rapidity of action (only 3 days) in the control of myoma-related bleeding.
- Open Access
- 23 August 2012
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 41 (4) , 459-464
Tissue characterization using mean gray value analysis in deep infiltrating endometriosis
Objectives To investigate differences in tissue characterization using three-dimensional sonographic mean gray value (MGV) between retrocervical and rectosigmoid deeply infiltrating endometriosis, and to assess intra- and interobserver concordance in MGV quantification. Methods In this retrospective study, stored ultrasound volumes from 50 premenopausal women (mean age, 32 years) with 57 histologically confirmed nodules of deep endometriosis were retrieved from our database for analysis. A single experienced operator had acquired all volumes. For each nodule, the MGV was evaluated using Virtual Organ Computer-aided AnaLysis (VOCAL) software with semiautomated sphere-sampling (1 cm3) from the central part of the nodule. In these patients the MGV was also quantified from the myometrium of the fundal part of the uterus. In addition, two observers calculated the MGV in a subset of 24 volumes in order to quantify inter- and intraobserver agreement using intraclass correlation coefficients (ICC). Results Mean MGV was significantly higher in rectosigmoid nodules (n = 34) than in nodules with a retrocervical location (n = 23) (23.863 vs 17.705; P < 0.001). MGV of the myometrium was significantly higher in comparison with that of nodules in both locations (P < 0.001 for both). Intra- and interobserver measurement reproducibility was excellent (ICC > 0.95). Conclusions Retrocervical and rectosigmoid endometriotic nodules display significantly different MGVs. Measurement of MGV is highly reproducible and its clinical value in the diagnosis and assessment of distribution of deep endometriosis should be assessed in future studies. Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.
- 23 August 2012
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 41 (4) , 459-464
Open AccessTissue characterization using mean gray value analysis in deep infiltrating endometriosis
Objectives To investigate differences in tissue characterization using three-dimensional sonographic mean gray value (MGV) between retrocervical and rectosigmoid deeply infiltrating endometriosis, and to assess intra- and interobserver concordance in MGV quantification. Methods In this retrospective study, stored ultrasound volumes from 50 premenopausal women (mean age, 32 years) with 57 histologically confirmed nodules of deep endometriosis were retrieved from our database for analysis. A single experienced operator had acquired all volumes. For each nodule, the MGV was evaluated using Virtual Organ Computer-aided AnaLysis (VOCAL) software with semiautomated sphere-sampling (1 cm3) from the central part of the nodule. In these patients the MGV was also quantified from the myometrium of the fundal part of the uterus. In addition, two observers calculated the MGV in a subset of 24 volumes in order to quantify inter- and intraobserver agreement using intraclass correlation coefficients (ICC). Results Mean MGV was significantly higher in rectosigmoid nodules (n = 34) than in nodules with a retrocervical location (n = 23) (23.863 vs 17.705; P < 0.001). MGV of the myometrium was significantly higher in comparison with that of nodules in both locations (P < 0.001 for both). Intra- and interobserver measurement reproducibility was excellent (ICC > 0.95). Conclusions Retrocervical and rectosigmoid endometriotic nodules display significantly different MGVs. Measurement of MGV is highly reproducible and its clinical value in the diagnosis and assessment of distribution of deep endometriosis should be assessed in future studies. Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.
- 1 March 2012
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 161 (1) , 92-95
Three-dimensional volume off-line analysis as compared to real-time ultrasound for assessing adnexal masses
- 1 March 2012
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 161 (1) , 92-95
Three-dimensional volume off-line analysis as compared to real-time ultrasound for assessing adnexal masses